MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, announces the development of a revolutionary technology: state-based imaginary-time evolution quantum ...
For speed, you need a system that keeps decisions and progress on a short leash. Below, Jon McNeill shares five key insights ...
Most health systems talk about accelerating AI adoption. Sudipto Srivastava, chief data and analytics officer at Montefiore Health System in New York City, is thinking about the opposite problem. Mr.
As a drug moves through research and regulatory processes, any mistakes in the data will be compounded. Small gaps that a ...
In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...
Tripo Studio’s Text to 3D Model feature converts written descriptions into detailed, production-ready 3D models with a single ...
Skolnick has developed AI-based approaches to predict protein structure and function that may help with drug discovery and ...
Phoenix Education Partners, Inc. ( PXED) Q2 2026 Earnings Call April 7, 2026 5:00 PM EDT Good afternoon, and welcome to Phoenix Education Partners Second Quarter Fiscal 2026 Earnings Conference Call. ...
South Carolina-based real estate giant Greystar plans to construct a 360-unit, four-building apartment complex and parking ...
SEALSQ Corp. (NASDAQ: LAES), ("SEALSQ" or "Company"), a leading developer of post-quantum semiconductors and cybersecurity solutions, today announces key financial and operational metrics for Q1 2026 ...
AI agents don’t see your website like humans do, and the accessibility tree is quickly becoming the interface that determines ...
6d
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results